MedTrace Logo

Virtual Reality in People With Persistent Postural-Perceptual Dizziness

NCT06366542 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2024-07-03

No results posted yet for this study

Summary

This study aimed to compare the effectiveness of virtual reality (VR) and vestibular rehabilitation therapy (VRT) in enhancing balance in individuals with Persistent Postural-Perceptual Dizziness (PPPD). The experimental group received VR combined with VRT and optokinetic stimulation, while the control group received VRT and optokinetic stimulation. The study involved 42 individuals diagnosed with PPPD and administered ten intervention sessions over six weeks. The study also examined the impact of VR on various aspects of PPPD, including dizziness, visual vertigo, mental well-being, sleep quality, fall risk, and overall quality of life.

Conditions

  • Vestibular Dizziness

Interventions

OTHER

Vestibular Rehabilitation Therapy (VRT)

The VRT exercises were composed of gaze stabilization, head motion and postural stability exercises with static and dynamic balance exercises.

OTHER

Virtual reality exercises

The VR exercises included watching theraputic videos using the virtual reality goggles with static and dynamic balance exercises.

OTHER

Optokinetic Stimulation exercises

Optokinetic Stimulation is a type of visual stimulation used to improve visual function and balance in patients with vestibular disorders.

Sponsors & Collaborators

  • University of Jordan

    lead OTHER

Principal Investigators

  • Alia A Alghwiri, PhD · The University of Jordan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2023-12-31
Completion
2024-03-01

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06366542 on ClinicalTrials.gov